These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 24345758

  • 1. A randomized, double-blind, placebo-controlled study of ziprasidone monotherapy in bipolar disorder with co-occurring lifetime panic or generalized anxiety disorder.
    Suppes T, McElroy SL, Sheehan DV, Hidalgo RB, Cosgrove VE, Gwizdowski IS, Feldman NS.
    J Clin Psychiatry; 2014 Jan; 75(1):77-84. PubMed ID: 24345758
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial.
    Keck PE, Versiani M, Potkin S, West SA, Giller E, Ice K, Ziprasidone in Mania Study Group.
    Am J Psychiatry; 2003 Apr; 160(4):741-8. PubMed ID: 12668364
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
    Sachs GS, Vanderburg DG, Karayal ON, Kolluri S, Bachinsky M, Cavus I.
    J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
    [Abstract] [Full Text] [Related]

  • 7. Ziprasidone treatment of refractory generalized anxiety disorder: a placebo-controlled, double-blind study.
    Lohoff FW, Etemad B, Mandos LA, Gallop R, Rickels K.
    J Clin Psychopharmacol; 2010 Apr; 30(2):185-9. PubMed ID: 20520293
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patient.
    Sheehan DV, Harnett-Sheehan K, Hidalgo RB, Janavs J, McElroy SL, Amado D, Suppes T.
    J Affect Disord; 2013 Feb 15; 145(1):83-94. PubMed ID: 22920718
    [Abstract] [Full Text] [Related]

  • 11. Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.
    Potkin SG, Keck PE, Segal S, Ice K, English P.
    J Clin Psychopharmacol; 2005 Aug 15; 25(4):301-10. PubMed ID: 16012271
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study.
    Vieta E, Ramey T, Keller D, English PA, Loebel AD, Miceli J.
    J Psychopharmacol; 2010 Apr 15; 24(4):547-58. PubMed ID: 19074536
    [Abstract] [Full Text] [Related]

  • 19. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
    Cutler AJ, Datto C, Nordenhem A, Minkwitz M, Acevedo L, Darko D.
    Clin Ther; 2011 Nov 15; 33(11):1643-58. PubMed ID: 22054797
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.